Evaluation of three Polymerase chain reaction tests targeting morphological transforming region II, UL-83 gene and glycoprotein O gene for the detection of Human Cytomegalovirus genome in clinical specimens of immunocompromised patients in Chennai, India
2006

Evaluating PCR Tests for Detecting Human Cytomegalovirus in Immunocompromised Patients

Sample size: 74 publication Evidence: high

Author Information

Author(s): Sowmya P, Madhavan HN, Therese KL

Primary Institution: L & T Microbiology Research Center, Vision Research Foundation, Chennai, India

Hypothesis

Can different PCR tests effectively detect HCMV DNA in clinical specimens from immunocompromised patients?

Conclusion

The study found that PCR targeting the mtr II region is the most effective method for detecting HCMV DNA in immunocompromised patients in Chennai, India.

Supporting Evidence

  • The PCR for mtr II region showed 100% sensitivity and negative predictive value.
  • Of the 48 specimens positive by the gold standard, all were positive for mtr II PCR.
  • The increase in clinical sensitivity for mtr II over UL 83 and gO PCRs was statistically significant.

Takeaway

Doctors can use a special test called PCR to find a virus called HCMV in sick patients, and one specific test works the best.

Methodology

The study evaluated three PCR tests on 92 clinical specimens from 74 immunocompromised patients, using pp65 antigenemia as the gold standard.

Limitations

The study may not be generalizable to other regions due to specific local factors.

Participant Demographics

Among the 74 patients, 47 were males and 27 females, with ages ranging from newborns to 67 years.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1743-422X-3-20

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication